GSK sinks to bottom of the FTSE on Zantac ruling
Court rules 70,000 plaintiffs can present evidenceGSK to seek appealBlood cancer drug receives positive resultsShares in GSK (GSK) fell 10% to the bottom of the FTSE 100 after a Delaware judge on Friday (31 May) allowed more than...
03 June 2024
